Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,194 | 553 | 96.8% |
| Education | $301.17 | 6 | 3.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,940 | 190 | $0 (2024) |
| PFIZER INC. | $929.05 | 59 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $690.72 | 36 | $0 (2024) |
| Amgen Inc. | $673.24 | 50 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $558.36 | 37 | $0 (2022) |
| Astellas Pharma US Inc | $484.71 | 22 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $414.48 | 24 | $0 (2024) |
| Lilly USA, LLC | $404.20 | 28 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $266.74 | 16 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $243.45 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,239 | 41 | AstraZeneca Pharmaceuticals LP ($273.72) |
| 2023 | $1,062 | 38 | Novo Nordisk Inc ($190.72) |
| 2022 | $1,119 | 60 | Novo Nordisk Inc ($536.32) |
| 2021 | $1,127 | 73 | Novo Nordisk Inc ($352.70) |
| 2020 | $720.03 | 55 | Novo Nordisk Inc ($187.77) |
| 2019 | $1,493 | 97 | Novo Nordisk Inc ($533.53) |
| 2018 | $1,520 | 110 | Novo Nordisk Inc ($495.03) |
| 2017 | $1,215 | 85 | Novo Nordisk Inc ($414.52) |
All Payment Transactions
559 individual payment records from CMS Open Payments — Page 22 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/07/2017 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $2.86 | General |
| Category: DERMATOLOGY | ||||||
| 05/30/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), INVOKAMET, XARELTO | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/24/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Diabetes | ||||||
| 05/17/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $11.59 | General |
| Category: Diabetes | ||||||
| 05/16/2017 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: DIABETES | ||||||
| 05/12/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $10.36 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/27/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: Diabetes | ||||||
| 04/24/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), TRADJENTA | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: DIABETES | ||||||
| 04/21/2017 | Allergan Inc. | VIBERZI (Drug) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/20/2017 | PFIZER INC. | CHANTIX (Drug), ELIQUIS, VIAGRA | Food and Beverage | In-kind items and services | $11.12 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 04/18/2017 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Endocrinology | ||||||
| 04/12/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $12.06 | General |
| Category: Diabetes | ||||||
| 03/31/2017 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Endocrinology | ||||||
| 03/28/2017 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: DIABETES | ||||||
| 03/27/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), INVOKAMET, XARELTO | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/22/2017 | PFIZER INC. | LYRICA (Drug) | Food and Beverage | In-kind items and services | $12.39 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 03/22/2017 | PFIZER INC. | LYRICA (Drug) | Food and Beverage | In-kind items and services | $1.99 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 03/21/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Diabetes | ||||||
| 03/15/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $8.37 | General |
| Category: Diabetes | ||||||
| 03/06/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $5.88 | General |
| Category: Diabetes | ||||||
| 03/03/2017 | PFIZER INC. | CHANTIX (Drug), ELIQUIS, VIAGRA | Food and Beverage | In-kind items and services | $11.10 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 03/01/2017 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: Respiratory | ||||||
| 02/28/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $11.30 | General |
| Category: Diabetes | ||||||
| 02/28/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $2.94 | General |
| Category: Diabetes | ||||||
| 02/23/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 372 | 576 | $91,030 | $45,498 |
| 2022 | 16 | 714 | 1,014 | $119,919 | $42,844 |
| 2021 | 20 | 1,275 | 2,022 | $210,142 | $113,039 |
| 2020 | 22 | 1,540 | 2,511 | $247,391 | $111,899 |
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 2 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 215 | 536 | $64,390 | $36,954 | 57.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 168 | 168 | $35,612 | $23,129 | 64.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 129 | 195 | $34,045 | $18,897 | 55.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 44 | 79 | $15,405 | $6,714 | 43.6% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 104 | 152 | $11,071 | $6,397 | 57.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 58 | 91 | $13,650 | $5,386 | 39.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 43 | 46 | $11,500 | $5,171 | 45.0% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 12 | 14 | $3,794 | $2,303 | 60.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 14 | 14 | $3,724 | $1,716 | 46.1% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 17 | 18 | $1,962 | $1,332 | 67.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 240 | 435 | $4,350 | $1,302 | 29.9% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 29 | 31 | $4,030 | $978.05 | 24.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 51 | 59 | $1,770 | $652.90 | 36.9% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 43 | 59 | $2,065 | $586.00 | 28.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 29 | 29 | $928.00 | $500.91 | 54.0% |
| 71046 | X-ray of chest, 2 views | Office | 2021 | 21 | 24 | $940.00 | $409.54 | 43.6% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent, preservation free | Office | 2021 | 17 | 17 | $459.00 | $349.01 | 76.0% |
| 90688 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent | Office | 2021 | 12 | 12 | $300.00 | $237.44 | 79.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 16 | 26 | $130.00 | $17.76 | 13.7% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2021 | 13 | 17 | $17.00 | $5.51 | 32.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 241 | 573 | $67,922 | $30,826 | 45.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 134 | 228 | $39,809 | $18,153 | 45.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 138 | 138 | $29,256 | $16,624 | 56.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 98 | 220 | $33,000 | $13,117 | 39.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 37 | 74 | $14,430 | $6,392 | 44.3% |
About Dr. Mazen Alsaqa, M.D
Dr. Mazen Alsaqa, M.D is a Internal Medicine healthcare provider based in Sterling Heights, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2012. The National Provider Identifier (NPI) number assigned to this provider is 1982968244.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mazen Alsaqa, M.D has received a total of $9,495 in payments from pharmaceutical and medical device companies, with $1,239 received in 2024. These payments were reported across 559 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($9,194).
As a Medicare-enrolled provider, Alsaqa has provided services to 3,901 Medicare beneficiaries, totaling 6,123 services with total Medicare billing of $313,281. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Sterling Heights, MI
- Active Since 07/01/2012
- Last Updated 01/31/2017
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1982968244
Products in Payments
- Ozempic (Drug) $912.80
- Victoza (Drug) $684.50
- Rybelsus (Drug) $562.67
- XARELTO (Drug) $470.14
- FARXIGA (Drug) $374.75
- Tresiba (Drug) $332.20
- EVENITY (Biological) $313.90
- LYRICA (Drug) $297.77
- XIFAXAN (Drug) $270.13
- TRULICITY (Drug) $255.15
- TRADJENTA (Drug) $241.48
- AIRSUPRA (Drug) $229.47
- ELIQUIS (Drug) $216.56
- Aimovig (Biological) $198.97
- JARDIANCE (Drug) $193.21
- GEMTESA (Drug) $172.83
- CHANTIX (Drug) $164.30
- TOUJEO (Drug) $156.31
- RYBELSUS (Drug) $145.31
- Vascepa (Drug) $134.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Sterling Heights
Dr. Syed Ali Muttaqi Husain, M.d, M.D
Internal Medicine — Payments: $54,045
Sandeep Garg, Md, MD
Internal Medicine — Payments: $37,573
Dr. Sami Asmar, M.d, M.D
Internal Medicine — Payments: $13,662
Dr. Zbigniew Purzycki, M.d, M.D
Internal Medicine — Payments: $12,572
Dr. Victor Al-Matchy, M.d, M.D
Internal Medicine — Payments: $12,259
Dr. Nicolas Marsheh, M.d, M.D
Internal Medicine — Payments: $10,498